Published in J Blood Med on April 29, 2011
Postural abnormality as a risk marker for leg deep venous thrombosis in Parkinson's disease. PLoS One (2013) 0.82
Increased risk of deep vein thrombosis and pulmonary thromboembolism in patients with aortic aneurysms: A nationwide cohort study. PLoS One (2017) 0.75
Is it necessary to use chemoprophylaxis in Indian patients after hip surgery? J Clin Orthop Trauma (2015) 0.75
Deep vein thrombosis, an unreported first manifestation of polyglandular autoimmune syndrome type III. Endocrinol Diabetes Metab Case Rep (2016) 0.75
Association of Methylenetetrahydrofolate Reductase C677T Polymorphism with Hyperhomocysteinemia and Deep Vein Thrombosis in the Iranian Population. Vasc Specialist Int (2015) 0.75
Challenges in the management of iliofemoral deep vein thrombosis in a resource limited setting: a case series. Pan Afr Med J (2014) 0.75
D-dimer testing for safe exclusion and risk stratification in patients with acute pulmonary embolism in primary care. J Res Med Sci (2015) 0.75
Incidence of Venous Thromboembolism in Patients Undergoing Major Hip Surgeries at a Single Institution: A Prospective Study. Open Orthop J (2016) 0.75
Molecular and Physical Mechanisms of Fibrinolysis and Thrombolysis from Mathematical Modeling and Experiments. Sci Rep (2017) 0.75
Quality improvement program reduces venous thromboembolism in infants and children with long-gap esophageal atresia (LGEA). Pediatr Surg Int (2016) 0.75
C20209T prothrombin gene mutation associated deep venous thrombosis in a hemodialysis patient. Clin Nephrol Case Stud (2014) 0.75
Popliteal venous aneurysm with deep venous thrombosis in the contralateral calf: report of a case. Surg Today (2013) 0.75
Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 16.17
Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med (2003) 11.00
Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med (1998) 9.43
Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med (2009) 9.17
The risk of recurrent venous thromboembolism in men and women. N Engl J Med (2004) 7.41
Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med (2003) 7.15
Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 7.12
A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med (1998) 7.08
Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med (1995) 6.86
Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet (1998) 6.04
Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology (1990) 6.04
Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med (1988) 5.81
Prevention of venous thromboembolism. Chest (2001) 5.59
A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N Engl J Med (1995) 4.71
Risk factors for venous thromboembolism. Circulation (2003) 4.64
Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost (2007) 4.09
Natural history of venous thromboembolism. Circulation (2003) 3.67
Accuracy of clinical assessment of deep-vein thrombosis. Lancet (1995) 3.45
Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J R Soc Med (1989) 3.44
The Wells rule does not adequately rule out deep venous thrombosis in primary care patients. Ann Intern Med (2005) 3.21
Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals. Council on Thrombosis (in consultation with the Council on Cardiovascular Radiology), American Heart Association. Circulation (1996) 2.69
A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. N Engl J Med (1972) 2.60
Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children. N Engl J Med (2004) 2.60
Oral contraceptives and the risk of venous thrombosis. N Engl J Med (2001) 2.57
Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*). A randomised, double-blind, non-inferiority trial. Thromb Haemost (2011) 2.53
Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med (1980) 2.50
Vena caval filters: a comprehensive review. Blood (2000) 2.39
Clinical practice. Prophylaxis for thromboembolism in hospitalized medical patients. N Engl J Med (2007) 2.39
Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest (2004) 2.19
Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood (1994) 2.14
Roentgen diagnosis of venous thrombosis in the leg. Arch Surg (1972) 2.12
Noninvasive diagnosis of deep venous thrombosis. McMaster Diagnostic Imaging Practice Guidelines Initiative. Ann Intern Med (1998) 2.03
Valves of the deep venous system: an overlooked risk factor. Blood (2009) 1.99
The origin of deep vein thrombosis: a venographic study. Br J Radiol (1971) 1.96
Antithrombotic therapy for venous thromboembolic disease. Chest (2001) 1.94
Complications of inferior vena cava filters. Am Surg (2003) 1.81
The diagnostic approach to acute venous thromboembolism. Clinical practice guideline. American Thoracic Society. Am J Respir Crit Care Med (1999) 1.80
Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients. Cochrane Database Syst Rev (2008) 1.79
Diagnosis of lower-limb deep venous thrombosis: a prospective blinded study of magnetic resonance direct thrombus imaging. Ann Intern Med (2002) 1.76
Limited value of patient history and physical examination in diagnosing deep vein thrombosis in primary care. Fam Pract (2005) 1.73
The effect of intermittently applied external pressure on the haemodynamics of the lower limb in man. Br J Surg (1972) 1.72
Risk factors for venous thrombosis: prevalence, risk, and interaction. Semin Hematol (1997) 1.68
Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands. J Pediatr (2001) 1.68
Biomarkers and venous thromboembolism. Arterioscler Thromb Vasc Biol (2009) 1.65
Physician practices in the management of venous thromboembolism: a community-wide survey. J Vasc Surg (1992) 1.63
The clinical diagnosis of deep venous thrombosis: integrating incidence, risk factors, and symptoms and signs. Arch Intern Med (1998) 1.61
The role of venous ultrasonography in the diagnosis of suspected deep venous thrombosis and pulmonary embolism. Ann Intern Med (1998) 1.58
Genetics of venous thrombosis. J Thromb Haemost (2009) 1.54
Intermittent pneumatic compression or graduated compression stockings for deep vein thrombosis prophylaxis? A systematic review of direct clinical comparisons. Ann Surg (2010) 1.48
Ultrasonography and diagnosis of venous thromboembolism. Circulation (2004) 1.47
Incidence of venous thromboembolism in infants and children: data from the National Hospital Discharge Survey. J Pediatr (2004) 1.46
Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev (2000) 1.45
Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thromb Haemost (1995) 1.44
Antithrombotic and thrombolytic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 1.41
Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database. BJOG (2001) 1.39
Prevention of venous thromboembolism after total knee replacement by high-dose aspirin or intermittent calf and thigh compression. Br Med J (1980) 1.37
Thrombotic side-effects of lower-limb phlebography. Lancet (1976) 1.33
Diagnosis, investigation, and management of deep vein thrombosis. BMJ (2003) 1.31
How we diagnose and treat deep vein thrombosis. Blood (2002) 1.29
DVT and pulmonary embolism: Part II. Treatment and prevention. Am Fam Physician (2004) 1.27
Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest (1995) 1.24
Interleukin 8 and venous thrombosis: evidence for a role of inflammation in thrombosis. Br J Haematol (2002) 1.22
New antithrombotic drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 1.21
Symptomatic lower extremity deep venous thrombosis: accuracy, limitations, and role of color duplex flow imaging in diagnosis. Radiology (1990) 1.18
Graduated compression stockings in the prevention of venous thromboembolism. Br J Surg (1999) 1.18
The value of mechanical methods of preventing postoperative calf vein thrombosis. Br J Surg (1974) 1.12
The effects of race/ethnicity and sex on the risk of venous thromboembolism. Curr Opin Pulm Med (2007) 1.10
Recent respiratory infection and risk of venous thromboembolism: case-control study through a general practice database. Int J Epidemiol (2011) 1.09
Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis. Arch Intern Med (1998) 1.05
Indications for catheter-directed thrombolysis in the management of acute proximal deep venous thrombosis. Arterioscler Thromb Vasc Biol (2010) 1.04
Long-term outcomes after deep vein thrombosis: postphlebitic syndrome and quality of life. J Gen Intern Med (2000) 1.04
Venous thromboembolism in children. Circulation (2006) 1.04
The fibrinolytic effects of intermittent pneumatic compression: mechanism of enhanced fibrinolysis. Ann Surg (1997) 1.03
Use of antithrombotic agents during pregnancy. Chest (2001) 1.02
A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip. Arch Intern Med (1989) 0.98
Air travel and the risk of thromboembolism. Intern Emerg Med (2010) 0.95
The role of thrombolysis in the clinical management of deep vein thrombosis. Arterioscler Thromb Vasc Biol (2011) 0.94
Limitations of D-dimer testing in unselected inpatients with suspected venous thromboembolism. Am J Med (2003) 0.94
The rate of bleeding complications after pharmacologic deep venous thrombosis prophylaxis: a systematic review of 33 randomized controlled trials. Arch Surg (2006) 0.94
Effectiveness of intermittent pulsatile elastic stockings for the prevention of calf and thigh vein thrombosis in patients undergoing elective knee surgery. Thromb Res (1979) 0.91
Aspirin in the prevention and treatment of venous thromboembolism. J Thromb Haemost (2006) 0.89
Pulmonary embolism in the elderly: a review on clinical, instrumental and laboratory presentation. Vasc Health Risk Manag (2008) 0.89
How we manage venous thromboembolism during pregnancy. Blood (2002) 0.87
D-dimer testing in pregnancy. Pathophysiol Haemost Thromb (2005) 0.87
Epidemiology of deep venous thrombosis during pregnancy and puerperium in Sudanese women. Vasc Health Risk Manag (2009) 0.87
Maternal plasma D-dimer levels in normal and complicated pregnancies. Obstet Gynecol (1993) 0.85
The effects of standard and low molecular weight heparin on bone nodule formation in vitro. Thromb Haemost (1998) 0.85
Deep venous thrombosis of extremities: role of MR imaging in the diagnosis. Radiology (1990) 0.84
D-dimer concentrations during normal pregnancy, as measured by ELISA. Thromb Res (1995) 0.83
Thromboembolic prophylaxis for total knee arthroplasty in Asian patients: a randomised controlled trial. J Orthop Surg (Hong Kong) (2009) 0.82
Lower limb venous dynamics in pregnant women. Surg Gynecol Obstet (1971) 0.81
Combined D-dimer and clinical probability are useful for exclusion of recurrent deep venous thrombosis. Am J Hematol (2007) 0.81
Acquired risk factors of venous thromboembolism in medical patients. Pathophysiol Haemost Thromb (2006) 0.80
Low-molecular-weight heparinoid orgaran is more effective than aspirin in the prevention of venous thromboembolism after surgery for hip fracture. Circulation (1996) 0.80
Risk factors for venous thromboembolism in children. Int Angiol (2004) 0.79
Assessment of fibrin(ogen) degradation products in preeclampsia using immunoblot, enzyme-linked immunosorbent assay, and latex-based agglutination. Obstet Gynecol (1991) 0.79
Rivaroxaban: an oral direct factor Xa inhibitor for the prevention of thromboembolism. Cardiol Rev (2009) 0.77
Fondaparinux sodium: a selective inhibitor of factor Xa. Am J Health Syst Pharm (2001) 0.77
Pregnancy and deep vein thrombosis. Semin Vasc Med (2001) 0.76
Tube thoracostomy: complications and its management. Pulm Med (2011) 1.61
Molecular diagnostics for lassa fever at Irrua specialist teaching hospital, Nigeria: lessons learnt from two years of laboratory operation. PLoS Negl Trop Dis (2012) 1.27
Knowledge of Hepatitis B Vaccine among Operating Room Personnel in Nigeria and Their Vaccination Status. Hepat Res Treat (2011) 0.98